» Articles » PMID: 10570270

Molecular and Functional Characterization of Mouse Signaling Lymphocytic Activation Molecule (SLAM): Differential Expression and Responsiveness in Th1 and Th2 Cells

Overview
Journal J Immunol
Date 1999 Nov 26
PMID 10570270
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Optimal T cell activation and expansion require engagement of the TCR plus costimulatory signals delivered through accessory molecules. SLAM (signaling lymphocytic activation molecule), a 70-kDa costimulatory molecule belonging to the Ig superfamily, was defined as a human cell surface molecule that mediated CD28-independent proliferation of human T cells and IFN-gamma production by human Th1 and Th2 clones. In this study, we describe the cloning of mouse SLAM and the production of mAb against it which reveal its expression on primary mouse T and B cells. Mouse SLAM is expressed on highly polarized Th1 and Th2 populations, and is maintained on Th1, but not on Th2 clones. Anti-mouse SLAM mAb augmented IFN-gamma production by Th1 cells and Th1 clones stimulated through the TCR, but did not induce IFN-gamma production by Th2 cells, nor their production of IL-4 or their proliferation. Mouse SLAM is a 75-kDa glycoprotein that upon tyrosine phosphorylation associates with the src homology 2-domain-containing protein tyrosine phosphatase SHP-2, but not SHP-1. Mouse SLAM also associates with the recently described human SLAM-associated protein. These studies may provide new insights into the regulation of Th1 responses.

Citing Articles

Role of signaling lymphocytic activation molecule family of receptors in the pathogenesis of rheumatoid arthritis: insights and application.

Zheng Y, Zhao J, Zhou M, Wei K, Jiang P, Xu L Front Pharmacol. 2023; 14:1306584.

PMID: 38027031 PMC: 10657885. DOI: 10.3389/fphar.2023.1306584.


SLAM-family receptors come of age as a potential molecular target in cancer immunotherapy.

Farhangnia P, Ghomi S, Mollazadehghomi S, Nickho H, Akbarpour M, Delbandi A Front Immunol. 2023; 14:1174138.

PMID: 37251372 PMC: 10213746. DOI: 10.3389/fimmu.2023.1174138.


T cell co-stimulatory and co-inhibitory pathways in atopic dermatitis.

Zheng C, Shi Y, Zou Y Front Immunol. 2023; 14:1081999.

PMID: 36993982 PMC: 10040887. DOI: 10.3389/fimmu.2023.1081999.


Heterogeneity of ILC2s in the Lungs.

Asaoka M, Kabata H, Fukunaga K Front Immunol. 2022; 13:918458.

PMID: 35757740 PMC: 9222554. DOI: 10.3389/fimmu.2022.918458.


Immune alterations in subacute sclerosing panencephalitis reflect an incompetent response to eliminate the measles virus.

Yentur S, Demirbilek V, Gurses C, Baris S, Kuru U, Ayta S PLoS One. 2021; 16(1):e0245077.

PMID: 33411786 PMC: 7790413. DOI: 10.1371/journal.pone.0245077.